OBJECTIVE This randomized clinical trial compared a novel cognitive-behavioral couple therapy (CBCT) and topical lidocaine for provoked vestibulodynia. METHOD Participants were 108 women (M age = 27.06) and their partners randomized to one of two treatments and assessed at pre- and post-treatment and 6-month follow-up via questionnaires pertaining to the primary outcomes of women's pain (numerical rating scales of pain intensity and unpleasantness), and secondary outcomes of pain anxiety (Pain Anxiety Symptoms Scale), both partners' sexual function (Female Sexual Function Index; International Index of Erectile Function), sexual distress (Female Sexual Distress Scale Revised), pain-related psychological distress (Pain Catastrophizing Scale), treatment satisfaction, and global ratings of improvements in pain and sexuality. RESULTS Intent-to-treat multilevel analyses showed that for women, CBCT yielded significantly more improvements than lidocaine in pain unpleasantness at 6-month follow-up, pain anxiety and pain catastrophizing at post-treatment and 6-month follow-up, and sexual distress at post-treatment, and resulted in better treatment satisfaction and global sexuality improvements at both time points. Partners significantly improved in their sexual function, sexual distress, and pain catastrophizing from pre- to post-treatment and pre-treatment to 6-month follow-up, with no significant group differences. Partners in the CBCT condition reported significantly greater treatment satisfaction at both time points, and greater sexuality improvements at post-treatment. CONCLUSIONS CBCT yielded better outcomes on more dimensions of provoked vestibulodynia than lidocaine. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

中文翻译：

---

认知行为夫妇疗法与利多卡因治疗诱发性前庭痛的比较：一项随机临床试验。

目的 本随机临床试验比较了新的认知行为夫妇疗法 (CBCT) 和局部利多卡因治疗诱发性前庭痛的效果。方法 参与者是 108 名女性（M 年龄 = 27.06）及其伴侣，随机分配到两种治疗中的一种，并在治疗前后和 6 个月的随访期间通过与女性疼痛的主要结果（数值评分量表）相关的问卷进行评估疼痛强度和不愉快），以及疼痛焦虑的次要结果（疼痛焦虑症状量表），双方的性功能（女性性功能指数；勃起功能国际指数），性困扰（女性性困扰量表修订版），疼痛 -相关的心理困扰（疼痛灾难化量表）、治疗满意度以及疼痛和性行为改善的全球评级。结果 意向性治疗多层次分析表明，对于女性而言，CBCT 在 6 个月随访时的疼痛不愉快、治疗后和 6 个月随访时的疼痛焦虑和疼痛灾难性以及性行为方面的改善明显多于利多卡因。治疗后的痛苦，并在两个时间点导致更好的治疗满意度和整体性改善。从治疗前到治疗后以及治疗前到 6 个月的随访，伴侣的性功能、性困扰和疼痛灾难显着改善，没有显着的组间差异。CBCT 条件下的伴侣在两个时间点都报告了显着更高的治疗满意度，并且在治疗后有更大的性改善。结论 与利多卡因相比，CBCT 在诱发前庭痛的更多方面产生了更好的结果。（PsycInfo 数据库记录 (c) 2021 APA，保留所有权利）。